The present invention discloses novel PPARgamma ligands of Formula (I) and pharmaceutically acceptable salts and solvates thereof. The present invention also discloses a method for treating osteoporosis by administration of a PPARgamma antagonist. n=2 - 4 and R1 - R5 are as in the application.
申请公布号
WO0027832(A3)
申请公布日期
2000.07.27
申请号
WO1999EP08477
申请日期
1999.11.09
申请人
GLAXO GROUP LIMITED;COLLINS, JON, LOREN;HOLMES, CHRISTOPHER, PATRICK;LENHARD, JAMES, MARTIN;WILLSON, TIMOTHY, MARK
发明人
COLLINS, JON, LOREN;HOLMES, CHRISTOPHER, PATRICK;LENHARD, JAMES, MARTIN;WILLSON, TIMOTHY, MARK
